ANAPTYSBIO INC (ANAB) Stock Balance Sheet
NASDAQ:ANAB - Nasdaq - US0327241065 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 98.64M | 123.08M | 35.97M | 71.30M | 495.70M | |||
| Marketable Securities | 241.30M | 262.29M | 354.94M | 369.90M | 52.40M | |||
| Receivables | 17.88M | 40.77M | 6.85M | 1.40M | 900.00K | |||
| Other Current Assets | 5.29M | 5.74M | 9.08M | 4.50M | 4.90M | |||
| Total Current Assets | 363.11M | 431.88M | 406.83M | 447.20M | 553.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 15.66M | 16.23M | 18.27M | 20.00M | 21.80M | |||
| Investments And Advances | 43.02M | 35.47M | 27.03M | 142.90M | 67.10M | |||
| Other Non-Current Assets | 256.00K | 256.00K | 256.00K | 300.00K | 300.00K | |||
| Total Non-Current Assets | 58.94M | 51.96M | 45.55M | 163.20M | 89.20M | |||
| TOTAL ASSETS | 422.05M | 483.83M | 452.39M | 610.40M | 643.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 34.37M | 41.43M | 32.74M | 23.30M | 14.40M | |||
| Accounts Payable | 6.12M | 4.00M | 4.70M | 2.80M | 1.70M | |||
| Other Current Liabilities | 3.54M | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 44.04M | 45.43M | 37.44M | 26.10M | 16.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 344.00M | 367.54M | 326.84M | 322.20M | 270.50M | |||
| Total Non-Current Liabilities | 344.00M | 367.54M | 326.84M | 322.20M | 270.50M | |||
| TOTAL LIABILITIES | 388.03M | 412.97M | 364.29M | 348.30M | 286.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -798.66M | -759.33M | -614.10M | -450.50M | -321.80M | |||
| Additional Paid In Capital | 832.49M | 829.86M | 702.97M | 717.80M | 678.60M | |||
| Common Shares | 30.00K | 30.00K | 27.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 161.00K | 305.00K | -797.00K | -5.20M | -400.00K | |||
| Shares Outstanding | 30.39M | 30.47M | 26.60M | 28.50M | 27.60M | |||
| Tangible Book Value per Share | 1.12 | 2.33 | 3.31 | 9.20 | 12.91 | |||
| Total Shareholders' Equity | 34.02M | 70.87M | 88.10M | 262.10M | 356.40M | |||
| TOTAL LIABILITIES AND EQUITY | 422.05M | 483.83M | 452.39M | 610.40M | 643.10M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 8.25 | 9.51 | 10.87 | 17.13 | 34.40 | |||
| Return On Assets (ROA) | -33.32% | -30.02% | -36.17% | -21.09% | -8.99% | |||
| Return On Equity (ROE) | -413.34% | -204.93% | -185.71% | -49.11% | -16.22% | |||
All data in USD , ROIC based on taxRate of 0.21